Most viewed articles
Showing 1 - 10 of 20
We are pleased to announce that the publication of the 2019 edition of The Legal 500 Europe, Middle East and Africa has seen us build on our 2018 success. Kennedys has been ranked in 14 practice areas, including three new rankings for our Paris office (dispute resolution, healthcare and life sciences and insurance), and a ‘top tier’ ranking for aviation in Belgium.
Early March 2019 marked the second annual #GenomicsConversation Week, the Genomics Education Programme’s annual week of action for all health professionals. The goal of this NHS initiative is to encourage conversation and awareness among all health professionals and to help them feel more comfortable discussing genomic testing with patients.
Artificial intelligence is prevalent across many areas of our day-to-day life and now increasingly so in medical products. This article focuses on the potential liability issues for such products, particularly in the healthcare sector.
In a global insurance environment facing change at an unprecedented rate, the London Market’s experience and expertise remains reassuringly consistent. As 2019 promises to continue down this evolutionary path, we offer our predictions on some of the London Market’s priority areas.
Diversity and inclusion is at the heart of Kennedys’ core values; being approachable, supportive, straightforward and distinctive. It’s something that is very important to us.
We are very pleased to confirm that, in addition to the firm’s gold level global partnership, we are a local sponsor of this year’s Inclusion@Lloyd’s Dive In Festival in four US cities – Chicago, Miami, New York and Philadelphia.
The government’s vision with regard to the life sciences industry offers some much needed reassurance to the sector. Indeed, the proposals appear to respond to the recommendations made to government by the House of Commons select committee on how to safeguard the industry from the impact of Brexit.
Our global expansion has been supported by a 20% increase in headcount worldwide to over 1900 personnel, with lateral partner hires and mergers across our offices boosting the partnership to 277 – representing a rise of 37%.
On 17 May 2018 the House of Commons Business, Energy and Industrial Strategy Committee (the Committee) published its report on “The impact of Brexit on the pharmaceutical sector”.
We are excited to confirm that we are the official gold level global partner for this year’s Inclusion@Lloyd’s Dive In Festival.